Industry News

Telehealthcare, Inc., a digital healthcare technology company building and commercializing solutions for the telemedicine marketplace, announced today the launch of its rebranded corporate website and key initiatives for the second half of 2016.. Telehealthcare, Inc.' s new website and business model reflect nearly two years of field work and intensive interaction with the medical community. Our field work has found three key market drivers:."/>
Telehealthcare, Inc. Announces Key Initiatives, Launches New Corporate Website
ANGLE plc, the specialist medtech company, is pleased to announce that it has initiated an ovarian cancer study in the United States, in addition to its recently opened European ovarian cancer study. The US study is being led by Dr Richard Moore at the University of Rochester Medical Center Wilmot Cancer Institute. Preparation and approvals for the US ovarian cancer study have been ongoing over recent months."/>
ANGLE plc ("the Company"): Initiation of 200 Patient United States Ovarian Cancer Study
Dr Reddy's growth tonic isn't working [Mint, New Delhi]
Adani Transmission Ltd. The firm plans to raise about $400 million through a dollar bond issue and has mandated seven banks to market it to offshore investors, according to two bankers aware of..."/>
Adani Transmission latest to tap offshore bonds as investor interest revives [Mint, New Delhi]
CRH Medical Corporation, a North American medical company that provides physicians with essential services and innovative products for the treatment of gastrointestinal diseases, today announced that it plans to release its financial results for the second quarter ended June 30, 2016, at 7:00 am ET on Thursday, July 28, 2016.. Second Quarter 2016, Conference Call Notification. CRH Medical will host a telephone conference call to..."/>
CRH Medical Announces Date for Second Quarter 2016 Results and Conference Call
Exact Sciences Corp. stock took a leap on Tuesday after the Madison company reported second-quarter revenues from its Cologuard colorectal cancer test more than doubled those from a year ago, and the number of patients using Cologuard topped expectations. Exact's stock jumped 40 percent, to $17.47 a share, in early activity and ended the day at $16.21, up $3.75, 30.1 percent higher than Monday's close at $12.46. Volume was high as 29.4 million shares were traded..."/>
Exact Sciences revenues rise and so do losses [The Wisconsin State Journal]
Centene Corp. has earmarked $300 million to cover potential losses from business the company picked up in its $6 billion acquisition of Health Net Inc. last year, company officials said Tuesday. During the company's second-quarter conference call Tuesday morning, executives disclosed that they had discovered $300 million in "premium deficiency reserves," or an estimate of a potential loss, mainly due to the increased use of substance abuse treatment centers in..."/>
Legacy Health Net business causes $300 million headache for Centene [St. Louis Post-Dispatch]
Cigna, based in Bloomfield, Conn., has filed plans to sell health policies to individuals and families who purchase their own coverage in the individual market. If the plans are approved by Illinois regulators, Cigna will start selling..."/>
Big news for Chicago-area Obamacare insurance exchange: Cigna seeks to join [Chicago Tribune]
Inovio Pharmaceuticals' experimental vaccine to combat the Zika virus, the Plymouth meeting biotech company said Tuesday. Inovio is developing its Zika vaccine with partner GeneOne Life Science in South Korea. Food and Drug Administration and Health Canada's Health Products and Food Branch have approved early-stage tests in 40 healthy adults, the company said."/>
Montco company doses first volunteer with experimental Zika vaccine [The Philadelphia Inquirer]
M and A Navigator: Deal pipeline –26 July
Insmed Incorporated. Investors who purchased or otherwise acquired shares between March 18, 2013 and June 8, 2016, are encouraged to contact the firm in advance of the September 13, 2016 lead plaintiff motion deadline.. If you are a shareholder who suffered a loss during the Class Period, click here to participate."/>
SHAREHOLDER NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm
Fiesta Restaurant Group Inc. will replace ExamWorks Group Inc. in the S&P SmallCap 600 after the close of trading on Wednesday, July 27. Leonard Green& Partners, L.P is acquiring ExamWorks Group in a deal expected to be completed on or about that date. Maiden Holdings Ltd. will replace Tumi Holdings Inc. in the S&P SmallCap 600 after the close of trading on Monday, August 1."/>
Fiesta Restaurant Group and Maiden Holdings to Join the S&P SmallCap 600
Ekso Bionics Holdings, Inc., a robotic exoskeleton company, today announced that it will release financial and business results for the second quarter 2016 after the close of trading on Thursday, July 28, 2016. The Company’ s management team will host a corresponding conference call beginning at 1:30 p.m. PT/ 4:30 p.m. ET to discuss the financial results and recent business developments.. Investors interested in listening to the conference call may..."/>
Ekso Bionics to Report Second Quarter 2016 Financial Results on July 28, 2016
CytRx Corporation. Investors who purchased or otherwise acquired shares between November 18, 2014 and July 11, 2016 inclusive, are encouraged to contact the Firm prior to the September 23, 2016 lead plaintiff motion deadline.. If you purchased shares of CytRx during the Class Period, please contact Joon M. Khang, Esquire, of Khang& Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by..."/>
IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit Against CytRx Corporation and Reminds Investors With Losses to Contact the Firm
BIND Therapeutics, Inc., a biotechnology company developing targeted and programmable therapeutics called ACCURINS ®, today announced that Pfizer Inc. prevailed at a Section 363 auction to purchase substantially all of BIND’ s assets. The winning bid of $40 million, subject to U.S. Bankruptcy Court approval for which a hearing is scheduled to take place on July 27, 2016, was selected as the highest and best bid."/>
BIND Therapeutics Determines Pfizer’s $40 Million Bid Is Highest and Best in 363 Auction for Substantially All of BIND’s Assets
Teva Pharmaceutical Industries Ltd. has priced a debt offering by its special purpose finance subsidiary Teva Pharmaceutical Finance Netherlands IV B.V., the company said. The offering consists of aCHF 300 m tranche of 0.125% fixed rate senior notes maturing in 2018; CHF 350 m of 0.500% fixed rate senior notes maturing in 2022; and CHF 350 m of 1.000% fixed rate senior notes maturing in 2025.. These notes are in addition to the..."/>
Teva Announces Pricing of Additional CHF 1bn of Senior Notes; Will Use for Actavis Generics Acquisition
Relypsa, Inc. have entered into a definitive agreement under which Galenica will acquire Relypsa, the companies said. Relypsa is a biopharmaceutical company based in Redwood City, Calif., with more than 400 employees. The company, founded in 2007, is focused on the discovery, development and commercialisation of polymeric medicines for patients with conditions that can be addressed in the gastrointestinal..."/>
Galenica to Acquire US GI Drugmaker Relypsa for USD 1.53bn
Aetna and Humana Inc. plan to vigorously defend the companies' pending merger in response to a US Department of Justice lawsuit seeking to block the transaction, the companies said. Last July, Aetna agreed acquire all outstanding shares of Humana for a combination of cash and stock valued at USD 48 bn. The combination brings together Humana's Medicare Advantage business with Aetna's portfolio and commercial capabilities to create a..."/>
Aetna and Humana Vow to “Vigorously Defend” Merger Following US DOJ Block
Parnell Pharmaceuticals Holdings Ltd., a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, announced today that it will report financial results for the six months ended June 30, 2016 on August 4, 2016 at 7:00 am ET.. Management will host a conference call on August 4, 2016 at 8 am ET to discuss financial results and answer questions. Investors and analysts may..."/>
Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Financials569 Articles
Information Technology531 Articles
Consumer Discretionary502 Articles
Industrials370 Articles
Health Care323 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.